Nuclear medicine benefits greatly from nanotechnology, particularly in the design of more effective radiopharmaceuticals for diagnosis and therapy. Nanoparticles can be used to deliver radioactive isotopes directly to cancer cells, minimizing damage to healthy tissues and improving treatment outcomes. The IAEA supports research in this field to develop new nanoparticle-based radiopharmaceuticals that can provide more accurate imaging and more effective cancer treatments.
